Scientific Literature Search

Source record

Structural Characteristics of α-Synuclein Oligomers.

Cremades N, Chen SW, Dobson CM.

Int Rev Cell Mol Biol · 2016-10-31

DOI: 10.1016/bs.ircmb.2016.08.010PMID: 28109332

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Altered Expression of <i>EPO</i> Might Underlie Hepatic Hemangiomas in <i>LRRK2</i> Knockout Mice.

Wu B, Xiao K, Zhang Z, Ma L.

Biomed Res Int · 2016-10-30

DOI: 10.1155/2016/7681259PMID: 27872856

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

LRRK2 Inhibits FAK Activity by Promoting FERM-mediated Autoinhibition of FAK and Recruiting the Tyrosine Phosphatase, SHP-2.

Choi I, Byun JW, Park SM, Jou I, Joe EH.

Exp Neurobiol · 2016-10-26

DOI: 10.5607/en.2016.25.5.269PMID: 27790061

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Alpha-synuclein in cutaneous small nerve fibers.

Siepmann T, Illigens BM, Barlinn K.

Neuropsychiatr Dis Treat · 2016-10-25

DOI: 10.2147/ndt.s117423PMID: 27822045

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau.

Rousseaux MW, de Haro M, Lasagna-Reeves CA, De Maio A, Park J, Jafar-Nejad P, Al-Ramahi I, Sharma A, See L, Lu N, Vilanova-Velez L, Klisch TJ, Westbrook TF, Troncoso JC, Botas J, Zoghbi HY.

Elife · 2016-10-25

DOI: 10.7554/elife.19809PMID: 27779468

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Oligomeric α-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease.

Pchelina S, Emelyanov A, Baydakova G, Andoskin P, Senkevich K, Nikolaev M, Miliukhina I, Yakimovskii A, Timofeeva A, Fedotova E, Abramycheva N, Usenko T, Kulabukhova D, Lavrinova A, Kopytova A, Garaeva L, Nuzhnyi E, Illarioshkin S, Zakharova E.

Neurosci Lett · 2016-10-22

DOI: 10.1016/j.neulet.2016.10.039PMID: 27780739

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

α-Synuclein-Based Animal Models of Parkinson's Disease: Challenges and Opportunities in a New Era.

Visanji NP, Brotchie JM, Kalia LV, Koprich JB, Tandon A, Watts JC, Lang AE.

Trends Neurosci · 2016-10-21

DOI: 10.1016/j.tins.2016.09.003PMID: 27776749

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Parkinson disease: LAG3 facilitates cell-to-cell spread of α-synuclein pathology.

Wood H.

Nat Rev Neurol · 2016-10-21

DOI: 10.1038/nrneurol.2016.164PMID: 27767033

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.

Abreu GM, Valença DC, Campos M, da Silva CP, Pereira JS, Araujo Leite MA, Rosso AL, Nicaretta DH, Vasconcellos LF, da Silva DJ, Della Coletta MV, Dos Santos JM, Gonçalves AP, Santos-Rebouças CB, Pimentel MM.

Neurosci Lett · 2016-10-21

DOI: 10.1016/j.neulet.2016.10.040PMID: 27777137

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Genetic analysis of CHCHD2 in a southern Spanish population.

Tejera-Parrado C, Jesús S, Huertas-Fernández I, Bernal-Bernal I, Bonilla-Toribio M, Córdoba-Tevar I, Abreu-Rodríguez I, Carrillo F, Bernal-Escudero M, Vargas-González L, Carballo M, Gómez-Garre P, Mir P.

Neurobiol Aging · 2016-10-21

DOI: 10.1016/j.neurobiolaging.2016.10.019PMID: 27839904

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

LRRK2 inhibitors and their potential in the treatment of Parkinson's disease: current perspectives.

Atashrazm F, Dzamko N.

Clin Pharmacol · 2016-10-20

DOI: 10.2147/cpaa.s102191PMID: 27799832

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Functional alterations of the dopaminergic and glutamatergic systems in spontaneous α-synuclein overexpressing rats.

Guatteo E, Rizzo FR, Federici M, Cordella A, Ledonne A, Latini L, Nobili A, Viscomi MT, Biamonte F, Landrock KK, Martini A, Aversa D, Schepisi C, D'Amelio M, Berretta N, Mercuri NB.

Exp Neurol · 2016-10-20

DOI: 10.1016/j.expneurol.2016.10.009PMID: 27771352

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

15.814 articles found

Structural Characteristics of α-Synuclein Oligomers.

Altered Expression of <i>EPO</i> Might Underlie Hepatic Hemangiomas in <i>LRRK2</i> Knockout Mice.

LRRK2 Inhibits FAK Activity by Promoting FERM-mediated Autoinhibition of FAK and Recruiting the Tyrosine Phosphatase, SHP-2.

Alpha-synuclein in cutaneous small nerve fibers.

TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau.

Oligomeric α-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease.

α-Synuclein-Based Animal Models of Parkinson's Disease: Challenges and Opportunities in a New Era.

Parkinson disease: LAG3 facilitates cell-to-cell spread of α-synuclein pathology.

Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.

Genetic analysis of CHCHD2 in a southern Spanish population.

LRRK2 inhibitors and their potential in the treatment of Parkinson's disease: current perspectives.

Functional alterations of the dopaminergic and glutamatergic systems in spontaneous α-synuclein overexpressing rats.

Filters